Our Life Sciences Group is pleased to present the "Year In Review" video, focusing on key compliance issues within the Pharma and Device sectors in Canada from 2023-2024. This review delves into the hottest topics, national news, provincial developments, legislative changes, guidelines, and industry dynamics.
Highlights include:
- US import of Canadian drugs
- National pharmacare and its current perspectives
- National strategy for rare diseases
- Updates from the Canada Drug Agency
- The Pan-Canadian Pharmaceutical Alliance
- The latest news from Innovative Medicines Canada
- Provincial news and legislative developments
- Patented Medicine Prices Review Board updates
- Key jurisprudential developments
- Advertising trends and dynamic industry shifts
